Jazz Pharmaceuticals PLC header image

Jazz Pharmaceuticals PLC

JAZZ

Equity

ISIN IE00B4Q5ZN47 / Valor 14769757

NASDAQ (2026-11-06)
USD 234.76+3.27%

Jazz Pharmaceuticals PLC
UMushroom community rating:

star star star star star
4.00 3 votes No rating yet
NegativeNeutralPositive

About company

Jazz Pharmaceuticals PLC is a biopharmaceutical company known for its focus on developing and commercializing innovative medicines aimed at addressing significant unmet medical needs. With a strong presence on the NASDAQ (JAZZ), the company has carved out a niche in the healthcare sector, particularly in the areas of sleep disorders, epilepsy, and oncology. Jazz Pharmaceuticals boasts a diverse portfolio of marketed medicines, with leading therapies that have made substantial impacts in their respective fields. The company's commitment to patient-focused and science-driven initiatives is evident in its robust pipeline, which is dedicated to pioneering research and development in oncology and neuroscience. Through its efforts, Jazz Pharmaceuticals aims to transform the lives of patients and their families by offering new, advanced therapeutic options.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

75.1%1Y
76.8%3Y
73.8%5Y

Performance

36.0%1Y
33.5%3Y
31.2%5Y

Volatility

Market cap

15069 M

Market cap (USD)

Daily traded volume (Shares)

887,564

Daily traded volume (Shares)

1 day high/low

124.03 / 122.1

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

3 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
4.67
Society:
starstarstarstarstar
4.33
Nature:
starstarstarstarstar
4.00
Eric Strauss
Switzerland, 12 Feb 2025
star star star star star
Könnte mit den Anlaufenenden Patenten, wirklich vielversprechend sein!
Admin UMushroom
Switzerland, 12 Feb 2025
star star star star star
.
Luba Schoenig
Switzerland, 12 Feb 2025
star star star star star
Jazz Pharmaceuticals reported a 14% year-over-year revenue increase in Q3 2024, driven by strong performance from Xywav, Epidiolex, and Rylaze. The company reaffirmed its 2024 total revenue guidance of 4.0-4.1 billion, supported by robust patient demand for Xywav (+17% sales growth) and Epidiolex’s

EQUITIES OF THE SAME SECTOR

Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.06%EUR 148.75
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.90%USD 37.43
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330445
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%EUR 77.40
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.53%EUR 103.20
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.78%CHF 133.61
Tecan Group Ltd.
Tecan Group Ltd. Tecan Group Ltd. Valor: 1210019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.68%CHF 257.60
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.32%CHF 89.45
COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%CHF 56.80
Medartis Holding AG
Medartis Holding AG Medartis Holding AG Valor: 38620023
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.05%CHF 109.60
Basilea Pharmaceutica Ltd, Allschwil
Basilea Pharmaceutica Ltd, Allschwil Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.56%CHF 71.00